Deals, Dupixent and GLP-1 drug shortages
Podcast: BioSpacePublished On: Wed Nov 29 2023
Description: This week we talk struggles with GLP-1 drug shortages and what that might mean for Novo/Lilly competitors; Regeneron and Sanofi positive results for Dupixent in COPD. Plus, Merck buys Caraway, Beigene's deal with Ensem, ups and downs for Flagship. Join BioSpace's Lori Ellis, Greg Slabodkin and Tyler Patchen as they discuss the most important biopharma news this week.
The note was deleted
The note was saved
Your message was sent